Treatment gap for people living with epilepsy in Madagascar.

Voa Ratsimbazafy (1, 2, 3) , Rakotobe Andrianabelina (4) , Sonia Randrianarisona (4) , Pierre-Marie Preux (1, 5, 6) , Peter Odermatt (7)

1 NETEC - Neuroépidémiologie Tropicale et Comparée
2 Service de Pharmacie Centrale [CHU Limoges]
3 UNILIM - Université de Limoges
4 Centre d'Appareillage d'Antananarivo
5 SIME - Service de l'Information Médicale et de l'Évaluation [CHU Limoges]
6 Laboratoire de Biostatistique et d'Informatique Médicale
7 Swiss Tropical and Public Health Institute [Basel]

Using an indirect assessment technique we assessed the epilepsy treatment gap (ETG) in Madagascar. We estimate the ETG in Madagascar to be 92%. However, given the sociological, economic and sanitary conditions of the country, it is likely that the true ETG is even higher than our estimate. Our study also documents the lack of access to treatment for patients in this developing country. The indirect method could be used to assess the treatment gaps of other chronic medical conditions.

Domaines: Sciences du Vivant [q-bio]; Santé publique et épidémiologie

Voa Ratsimbazafy, Rakotobe Andrianabelina, Sonia Randrianarisona, Pierre-Marie Preux, Peter Odermatt. Treatment gap for people living with epilepsy in Madagascar.. Tropical Doctor, 2011, 41 (1), pp.38-9. ⟨10.1258/td.2010.100254⟩. ⟨hal-00608568⟩